J&J innovation arm backs biotech company’s $60.75M funding round

Johnson & Johnson Innovation joined in the $60.75 million series A funding round for SonoThera, a biotech genetic therapy company.

Advertisement

SonoThera created an ultrasound-guided, non-viral gene therapy platform designed to provide patients with genetic medicines via sonoporation. The financing will be used to support the continued development of the platform, according to a Dec. 5 SonoThera news release. 

The round was led by Arch Venture Partners.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.